
Sign up to save your podcasts
Or


John A. Kessler MD is Davee Professor of Stem Cell Biology and Chairman of the Davee Department of Neurology, Northwestern University Medical School. He discusses applying molecular neurobiology to clinical problems of spinal cord injury and stroke. Dr. Bruce Bloom hosts.
John A. Kessler MD, Davee Professor of Stem Cell Biology and Chairman of the Davee Department of Neurology at Northwestern University Medical School, is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about the biology of embryonic stem cells and neural stem cells, including the mechanisms regulating neuronal and glial differentiation.
Loren D. Walensky MD, PhD, Assistant Professor of Pediatric Oncology at Harvard Medical School and Medical Director of the Program of Cancer Chemical Biology at the Dana-Farber Cancer Institute in Boston, discusses life as a research scientist in cancer research.
Dr. Loren Walensky, Assistant Professor of Pediatric Oncology at Harvard Medical School and Medical Director of the Program of Cancer Chemical Biology at the Dana-Farber Cancer Institute discusses the biology of cell death and how a new chemical technology is yielding a host of new tools to study and treat diseases, like cancer, that are characterized by an imbalance of cellular life and death.
Almost every day, you hear or read about people working more for less, and doctors are no different with employers, insurers and government payers looking for ways to slow rising health costs. So how do doctors maximize revenue in this challenging environment? Tim Dugan, co-founder of private equity firm Water Street Healthcare Partners, one of the largest such funds focused solely on the health-care industry, tells the Chicago Tribune's Bruce Japsen about private equity and how it works with doctors to improve their revenue.
A new trend is emerging in medical diagnosis. It's called point-of-care diagnostics. Tim Dugan, managing partner and co-founder of Water Street Healthcare Partners, one of the nation's largest private equity funds focused solely on health care, tells the Chicago Tribune's Bruce Japsen about moving diagnostic tests to the patients' bedside and the point of care.
With the volatility of the stock market and still low interest rates, private equity continues to have a greater role in the health care industry. But can private equity improve patient safety outcomes with the entire industry under pressure to improve quality? Tim Dugan, co-founder of Water Street Healthcare Partners, a private equity fund focused solely on the health care industry, tells the Chicago Tribune's Bruce Japsen about what private investment has to offer for quality in medical care.
From the publisher's feed

7,971 Listeners

29,186 Listeners